Skip to main content
Top
Published in: Respiratory Research 1/2022

Open Access 01-12-2022 | Chronic Obstructive Lung Disease | Research

Combining single-cell RNA sequencing of peripheral blood mononuclear cells and exosomal transcriptome to reveal the cellular and genetic profiles in COPD

Authors: Yanli Pei, Yuxi Wei, Boshizhang Peng, Mengqi Wang, Wei Xu, Zhe Chen, Xindi Ke, Lei Rong

Published in: Respiratory Research | Issue 1/2022

Login to get access

Abstract

Background

It has been a long-held consensus that immune reactions primarily mediate the pathology of chronic obstructive pulmonary disease (COPD), and that exosomes may participate in immune regulation in COPD. However, the relationship between exosomes and peripheral immune status in patients with COPD remains unclear.

Methods

In this study, we sequenced plasma exosomes and performed single-cell RNA sequencing on peripheral blood mononuclear cells (PBMCs) from patients with COPD and healthy controls. Finally, we constructed competing endogenous RNA (ceRNA) and protein–protein interaction (PPI) networks to delineate the interactions between PBMCs and exosomes within COPD.

Results

We identified 135 mRNAs, 132 lncRNAs, and 359 circRNAs from exosomes that were differentially expressed in six patients with COPD compared with four healthy controls. Functional enrichment analyses revealed that many of these differentially expressed RNAs were involved in immune responses including defending viral infection and cytokine–cytokine receptor interaction. We also identified 18 distinct cell clusters of PBMCs in one patient and one control by using an unsupervised cluster analysis called uniform manifold approximation and projection (UMAP). According to resultant cell identification, it was likely that the proportions of monocytes, dendritic cells, and natural killer cells increased in the COPD patient we tested, meanwhile the proportions of B cells, CD4 + T cells, and naïve CD8 + T cells declined. Notably, CD8 + T effector memory CD45RA + (Temra) cell and CD8 + effector memory T (Tem) cell levels were elevated in patient with COPD, which were marked by their lower capacity to differentiate due to their terminal differentiation state and lower reactive capacity to viral pathogens.

Conclusions

We generated exosomal RNA profiling and single-cell transcriptomic profiling of PBMCs in COPD, described possible connection between impaired immune function and COPD development, and finally determined the possible role of exosomes in mediating local and systemic immune reactions.
Appendix
Available only for authorised users
Literature
1.
go back to reference Soriano JB, et al. Prevalence and attributable health burden of chronic respiratory diseases, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet Respir Med. 2020;8(6):585–96.CrossRef Soriano JB, et al. Prevalence and attributable health burden of chronic respiratory diseases, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet Respir Med. 2020;8(6):585–96.CrossRef
2.
go back to reference Adeloye D, et al. Global, regional, and national prevalence of, and risk factors for, chronic obstructive pulmonary disease (COPD) in 2019: a systematic review and modelling analysis. Lancet Respir Med. 2022;10(5):447–58.PubMedPubMedCentralCrossRef Adeloye D, et al. Global, regional, and national prevalence of, and risk factors for, chronic obstructive pulmonary disease (COPD) in 2019: a systematic review and modelling analysis. Lancet Respir Med. 2022;10(5):447–58.PubMedPubMedCentralCrossRef
4.
go back to reference Barnes PJ. Inflammatory mechanisms in patients with chronic obstructive pulmonary disease. J Allergy Clin Immunol. 2016;138(1):16–27.PubMedCrossRef Barnes PJ. Inflammatory mechanisms in patients with chronic obstructive pulmonary disease. J Allergy Clin Immunol. 2016;138(1):16–27.PubMedCrossRef
5.
go back to reference Agustí A, et al. Pathogenesis of chronic obstructive pulmonary disease: understanding the contributions of gene–environment interactions across the lifespan. Lancet Respir Med. 2022;10(5):512–24.PubMedCrossRef Agustí A, et al. Pathogenesis of chronic obstructive pulmonary disease: understanding the contributions of gene–environment interactions across the lifespan. Lancet Respir Med. 2022;10(5):512–24.PubMedCrossRef
6.
go back to reference Barnes PJ. Inflammatory endotypes in COPD. Allergy. 2019;74(7):1249–56.PubMed Barnes PJ. Inflammatory endotypes in COPD. Allergy. 2019;74(7):1249–56.PubMed
7.
go back to reference Moll M, et al. Development of a blood-based transcriptional risk score for chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2022;205(2):161–70.PubMedCrossRef Moll M, et al. Development of a blood-based transcriptional risk score for chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2022;205(2):161–70.PubMedCrossRef
8.
go back to reference Yun JH, et al. An interferon inducible signature of airway disease from blood gene expression profiling. Eur Respir J. 2021. Yun JH, et al. An interferon inducible signature of airway disease from blood gene expression profiling. Eur Respir J. 2021.
9.
go back to reference Bahr TM, et al. Peripheral blood mononuclear cell gene expression in chronic obstructive pulmonary disease. Am J Respir Cell Mol Biol. 2013;49(2):316–23.PubMedPubMedCentralCrossRef Bahr TM, et al. Peripheral blood mononuclear cell gene expression in chronic obstructive pulmonary disease. Am J Respir Cell Mol Biol. 2013;49(2):316–23.PubMedPubMedCentralCrossRef
10.
go back to reference Słomka A, et al. Extracellular vesicles small RNA clusters: hit the nail on the head of liver cancer detection. Hepatobil Surg Nutr. 2022;11(1):100–2.CrossRef Słomka A, et al. Extracellular vesicles small RNA clusters: hit the nail on the head of liver cancer detection. Hepatobil Surg Nutr. 2022;11(1):100–2.CrossRef
11.
go back to reference Russell DW, Genschmer KR, Blalock JE. Extracellular Vesicles as Central Mediators of COPD Pathophysiology. Annu Rev Physiol. 2022;84:631–54.PubMedCrossRef Russell DW, Genschmer KR, Blalock JE. Extracellular Vesicles as Central Mediators of COPD Pathophysiology. Annu Rev Physiol. 2022;84:631–54.PubMedCrossRef
12.
go back to reference Cock PJ, et al. The Sanger FASTQ file format for sequences with quality scores, and the Solexa/Illumina FASTQ variants. Nucleic Acids Res. 2010;38(6):1767–71.PubMedCrossRef Cock PJ, et al. The Sanger FASTQ file format for sequences with quality scores, and the Solexa/Illumina FASTQ variants. Nucleic Acids Res. 2010;38(6):1767–71.PubMedCrossRef
16.
go back to reference Welsh JA, et al. Towards defining reference materials for measuring extracellular vesicle refractive index, epitope abundance, size and concentration. J Extracell Vesicles. 2020;9(1):1816641.PubMedPubMedCentralCrossRef Welsh JA, et al. Towards defining reference materials for measuring extracellular vesicle refractive index, epitope abundance, size and concentration. J Extracell Vesicles. 2020;9(1):1816641.PubMedPubMedCentralCrossRef
17.
go back to reference Zheng C, et al. Landscape of infiltrating T cells in liver cancer revealed by single-cell sequencing. Cell. 2017;169(7):1342-1356.e16.PubMedCrossRef Zheng C, et al. Landscape of infiltrating T cells in liver cancer revealed by single-cell sequencing. Cell. 2017;169(7):1342-1356.e16.PubMedCrossRef
18.
go back to reference Wang T, et al. Single-cell RNA sequencing reveals the sustained immune cell dysfunction in the pathogenesis of sepsis secondary to bacterial pneumonia. Genomics. 2021;113(3):1219–33.PubMedCrossRef Wang T, et al. Single-cell RNA sequencing reveals the sustained immune cell dysfunction in the pathogenesis of sepsis secondary to bacterial pneumonia. Genomics. 2021;113(3):1219–33.PubMedCrossRef
22.
go back to reference Zhang L, et al. Single-cell analyses inform mechanisms of myeloid-targeted therapies in colon cancer. Cell. 2020;181(2):442-459.e29.PubMedCrossRef Zhang L, et al. Single-cell analyses inform mechanisms of myeloid-targeted therapies in colon cancer. Cell. 2020;181(2):442-459.e29.PubMedCrossRef
23.
go back to reference Hayward S, et al. The CD151-midkine pathway regulates the immune microenvironment in inflammatory breast cancer. J Pathol. 2020;251(1):63–73.PubMedCrossRef Hayward S, et al. The CD151-midkine pathway regulates the immune microenvironment in inflammatory breast cancer. J Pathol. 2020;251(1):63–73.PubMedCrossRef
24.
go back to reference Chen BB, et al. A combinatorial F box protein directed pathway controls TRAF adaptor stability to regulate inflammation. Nat Immunol. 2013;14(5):470–9.PubMedPubMedCentralCrossRef Chen BB, et al. A combinatorial F box protein directed pathway controls TRAF adaptor stability to regulate inflammation. Nat Immunol. 2013;14(5):470–9.PubMedPubMedCentralCrossRef
25.
26.
go back to reference Wang Q, et al. The leucine-rich repeat region of CARMIL1 regulates IL-1-mediated ERK activation, MMP expression, and collagen degradation. Cell Rep. 2020;31(13): 107781.PubMedPubMedCentralCrossRef Wang Q, et al. The leucine-rich repeat region of CARMIL1 regulates IL-1-mediated ERK activation, MMP expression, and collagen degradation. Cell Rep. 2020;31(13): 107781.PubMedPubMedCentralCrossRef
27.
go back to reference Finney LJ, et al. Human rhinovirus impairs the innate immune response to bacteria in alveolar macrophages in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2019;199(12):1496–507.PubMedCrossRef Finney LJ, et al. Human rhinovirus impairs the innate immune response to bacteria in alveolar macrophages in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2019;199(12):1496–507.PubMedCrossRef
28.
go back to reference Mizumura K, Gon Y. Iron-regulated reactive oxygen species production and programmed cell death in chronic obstructive pulmonary disease. Antioxidants (Basel). 2021; 10(10). Mizumura K, Gon Y. Iron-regulated reactive oxygen species production and programmed cell death in chronic obstructive pulmonary disease. Antioxidants (Basel). 2021; 10(10).
29.
go back to reference Qin K, et al. The functions of CD4 T-helper lymphocytes in chronic obstructive pulmonary disease. Acta Biochim Biophys Sin. 2022;54(2):173–8.PubMedCrossRef Qin K, et al. The functions of CD4 T-helper lymphocytes in chronic obstructive pulmonary disease. Acta Biochim Biophys Sin. 2022;54(2):173–8.PubMedCrossRef
30.
go back to reference Wang Z, et al. A refined view of airway microbiome in chronic obstructive pulmonary disease at species and strain-levels. Front Microbiol. 2020;11:1758.PubMedPubMedCentralCrossRef Wang Z, et al. A refined view of airway microbiome in chronic obstructive pulmonary disease at species and strain-levels. Front Microbiol. 2020;11:1758.PubMedPubMedCentralCrossRef
31.
go back to reference Zhang M, et al. LINC00324 affects non-small cell lung cancer cell proliferation and invasion through regulation of the miR-139-5p/IGF1R axis. Mol Cell Biochem. 2020;473(1–2):193–202.PubMedCrossRef Zhang M, et al. LINC00324 affects non-small cell lung cancer cell proliferation and invasion through regulation of the miR-139-5p/IGF1R axis. Mol Cell Biochem. 2020;473(1–2):193–202.PubMedCrossRef
33.
go back to reference Moloney GM, Cryan JF, Clarke G. “Digging in the Dirt” faecal microRNAs as dietary biomarkers of host-microbe interactions. Hepatobil Surg Nutr. 2022;11(2):292–4.CrossRef Moloney GM, Cryan JF, Clarke G. “Digging in the Dirt” faecal microRNAs as dietary biomarkers of host-microbe interactions. Hepatobil Surg Nutr. 2022;11(2):292–4.CrossRef
34.
go back to reference Vinchure OS, et al. miR-490 suppresses telomere maintenance program and associated hallmarks in glioblastoma. Cell Mol Life Sci CMLS. 2021;78(5):2299–314.PubMedCrossRef Vinchure OS, et al. miR-490 suppresses telomere maintenance program and associated hallmarks in glioblastoma. Cell Mol Life Sci CMLS. 2021;78(5):2299–314.PubMedCrossRef
35.
go back to reference Freeman CM, et al. Lung dendritic cell expression of maturation molecules increases with worsening chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2009;180(12):1179–88.PubMedPubMedCentralCrossRef Freeman CM, et al. Lung dendritic cell expression of maturation molecules increases with worsening chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2009;180(12):1179–88.PubMedPubMedCentralCrossRef
36.
go back to reference Polverino F, et al. B cells in chronic obstructive pulmonary disease: moving to center stage. Am J Physiol Lung Cell Mol Physiol. 2016;311(4):L687–95.PubMedPubMedCentralCrossRef Polverino F, et al. B cells in chronic obstructive pulmonary disease: moving to center stage. Am J Physiol Lung Cell Mol Physiol. 2016;311(4):L687–95.PubMedPubMedCentralCrossRef
37.
go back to reference Fernandes JR, et al. Age-associated phenotypic imbalance in TCD4 and TCD8 cell subsets: comparison between healthy aged, smokers, COPD patients and young adults. Immun Ageing. 2022;19(1):9.PubMedPubMedCentralCrossRef Fernandes JR, et al. Age-associated phenotypic imbalance in TCD4 and TCD8 cell subsets: comparison between healthy aged, smokers, COPD patients and young adults. Immun Ageing. 2022;19(1):9.PubMedPubMedCentralCrossRef
39.
go back to reference Pastor MD, et al. Identification of proteomic signatures associated with lung cancer and COPD. J Proteomics. 2013;89:227–37.PubMedCrossRef Pastor MD, et al. Identification of proteomic signatures associated with lung cancer and COPD. J Proteomics. 2013;89:227–37.PubMedCrossRef
41.
go back to reference Mellett L, Khader SA. S100A8/A9 in COVID-19 pathogenesis: impact on clinical outcomes. Cytokine Growth Factor Rev. 2022;63:90–7.PubMedCrossRef Mellett L, Khader SA. S100A8/A9 in COVID-19 pathogenesis: impact on clinical outcomes. Cytokine Growth Factor Rev. 2022;63:90–7.PubMedCrossRef
42.
go back to reference Southworth T, et al. The relationship between airway immunoglobulin activity and eosinophils in COPD. J Cell Mol Med. 2021;25(4):2203–12.PubMedCrossRef Southworth T, et al. The relationship between airway immunoglobulin activity and eosinophils in COPD. J Cell Mol Med. 2021;25(4):2203–12.PubMedCrossRef
43.
go back to reference Häcker H, et al. Specificity in Toll-like receptor signalling through distinct effector functions of TRAF3 and TRAF6. Nature. 2006;439(7073):204–7.PubMedCrossRef Häcker H, et al. Specificity in Toll-like receptor signalling through distinct effector functions of TRAF3 and TRAF6. Nature. 2006;439(7073):204–7.PubMedCrossRef
44.
go back to reference Knobloch J, et al. The T-helper cell type 1 immune response to gram-negative bacterial infections is impaired in COPD. Am J Respir Crit Care Med. 2011;183(2):204–14.PubMedCrossRef Knobloch J, et al. The T-helper cell type 1 immune response to gram-negative bacterial infections is impaired in COPD. Am J Respir Crit Care Med. 2011;183(2):204–14.PubMedCrossRef
45.
go back to reference Roos AB, Stampfli MR. Targeting Interleukin-17 signalling in cigarette smoke-induced lung disease: mechanistic concepts and therapeutic opportunities. Pharmacol Ther. 2017;178:123–31.PubMedCrossRef Roos AB, Stampfli MR. Targeting Interleukin-17 signalling in cigarette smoke-induced lung disease: mechanistic concepts and therapeutic opportunities. Pharmacol Ther. 2017;178:123–31.PubMedCrossRef
46.
go back to reference Ford JA, et al. Asthma, chronic obstructive pulmonary disease, and subsequent risk for incident rheumatoid arthritis among women: a prospective cohort study. Arthritis Rheumatol. 2020;72(5):704–13.PubMedPubMedCentralCrossRef Ford JA, et al. Asthma, chronic obstructive pulmonary disease, and subsequent risk for incident rheumatoid arthritis among women: a prospective cohort study. Arthritis Rheumatol. 2020;72(5):704–13.PubMedPubMedCentralCrossRef
Metadata
Title
Combining single-cell RNA sequencing of peripheral blood mononuclear cells and exosomal transcriptome to reveal the cellular and genetic profiles in COPD
Authors
Yanli Pei
Yuxi Wei
Boshizhang Peng
Mengqi Wang
Wei Xu
Zhe Chen
Xindi Ke
Lei Rong
Publication date
01-12-2022
Publisher
BioMed Central
Published in
Respiratory Research / Issue 1/2022
Electronic ISSN: 1465-993X
DOI
https://doi.org/10.1186/s12931-022-02182-8

Other articles of this Issue 1/2022

Respiratory Research 1/2022 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine